NCT02707107View on ClinicalTrials.gov

MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Serious Gram-negative Infections

Interventions

DRUG

Intravenous infusions of WCK 5222

DRUG

Placebo

Trial Locations (1)

66211

Quintiles, Overland Park

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Quintiles, Inc.

INDUSTRY

lead

Wockhardt

INDUSTRY